期刊文献+

胆管癌发生的相关危险因素病例对照研究 被引量:6

Case-control study of risk factors in cholangiocarcinoma
原文传递
导出
摘要 目的探讨肝内胆管癌(ICC)和肝外胆管癌(ECC)发生的相关危险因素。方法收集北京协和医院1998年至2008年190例胆管癌患者的临床资料,其中ICC61例,ECC129例,并以380名健康人作为对照组。统计所有参与者的肝脏疾病、家族病史、糖尿病、吸烟、饮酒等资料。结果ICC患者的HBsAg(+)和anti-HBc(+)、HBsAg(-)和anti—HBc(+)、胆管结石的发生率分别为27.9%、50.8%和14.8%,ECC患者的糖尿病患病率、胆囊结石发生率、胆管结石发生率和胆囊切除率分别为18.6%、15.5%、18.6%和13.2%,均高于对照组(P〈0.05)。ICC与ECC相比,ICC患者有较高的肝硬化患病率(P〈0.05)。结论胆管结石、肝硬化和HBV感染是ICC发生的危险因素,而糖尿病、胆囊结石、胆管结石和胆囊切除史为ECC发生的危险因素,胆管结石是ICC和ECC发生的共同危险因素。 Objective To invenstigate the risk factors of intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC). Methods The clinicopathological data of 190 patients with cholangiocarcinomas (61 ICC and 129 ECC) diagnosed and treated in the Peking Union Medical College Hospital between 1998 and 2008 were collected. The clinicopathological data of 380 matched healthy controls were also collected. The information about liver diseases, family history, diabetes, smoking and drinking were recorded and analyzed. Results The positive rate of HBsAg( + ) and anti-HBc( + ), HBsAg( - ) and anti-HBc( + ) and the incidence of choledoeholithiasis or hepatolithiasis in ICC patients were 27.9% , 50.8% and 14.8% , respectively. The incidence of diabetes mellitus, cholecystolithiasis, choledocholithiasis or hepatolithiasis and previous cholecystectomy in ECC patients were 18.6%, 15.5%, 18.6% and 13.2% , respectively. The incidences of all above mentioned factors in the ICC or ECC patients were significantly higher than that in the controls ( P 〈 0. 05 ). Compared with the patients with ECC, the ICC patients had a significantly higher cirrhosis rate (P 〈 0.05). Conclusion Our study results show that choledocholithiasis or hepatolithiasis, liver cirrhosis and chronic HBV infection are possible risk factors for intrahepatic cholangiocarcinoma, while choledocholithiasis or hepatolithiasis, diabetes mellitus, cholecystolithiasis, history of cholecystectomy are risk factors for extrahepatic cholangiocarcinoma.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第10期759-763,共5页 Chinese Journal of Oncology
基金 北京市重点学科资助项目(HK100230446)
关键词 胆管癌 肝炎病毒 危险因素 Cholangiocarcinoma Hepatitis viruses Risk factor
作者简介 通信作者:何小东,Email:hexpumch@sina.com
  • 相关文献

参考文献5

二级参考文献49

共引文献110

同被引文献53

  • 1Vincenzo Cardinale,Rossella Semeraro,Alessia Torrice,Manuela Gatto,Cristina Napoli,Maria Consiglia Bragazzi,Raffaele Gentile,Domenico Alvaro.Intra-hepatic and extra-hepatic cholangiocarcinoma:New insight into epidemiology and risk factors[J].World Journal of Gastrointestinal Oncology,2010,2(11):407-416. 被引量:14
  • 2Zhen-Yu Liu,Yan-Ming Zhou,Le-Hua Shi and Zheng-Feng YinAuthor Affiliations:Molecular Oncology Laboratory and Department of Comprehensive Treatment I,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200438,China,Department of Hepato-Biliary-Pancreato-Vascular Surgery,First Affiliated Hospital,Xiamen University,Xiamen 361003,China.Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis:a case-control study[J].Hepatobiliary & Pancreatic Diseases International,2011,10(6):626-631. 被引量:27
  • 3Ru-Fu Chen, Zhi-Hua Li, Sheng-Quan Zou and Ji-Sheng Chen Guangzhou, China Department of Hepatobiliary Surgery,Hospital of Zhongshan University, Guangzhou 510120, China ,Department of Surgery,Tongji Hospital, Wuhan 430030, China.Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2005,4(1):71-74. 被引量:9
  • 4Yukio Oshiro,Kazuhiro Takahashi,Ryoko Sasaki,Tadashi Kondo,Shingo Sakashita,Nobuhiro Ohkohchi.Adjuvant surgery for advanced extrahepatic cholangiocarcinoma[J].World Journal of Gastroenterology,2013,19(40):6934-6938. 被引量:1
  • 5Takehiro Okabayashi,Yasuo Shima,Tatsuaki Sumiyoshi,Akihito Kozuki,Satoshi Ito,Yasuhiro Ogawa,Michiya Kobayashi,Kazuhiro Hanazaki.Diagnosis and management of insulinoma[J].World Journal of Gastroenterology,2013,19(6):829-837. 被引量:93
  • 6Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer [J]. Semin Liver Dis, 1999, 19(3):271-285. DOI:10.1055/s-2007- 1007117.
  • 7Tao LY, He XD, Cai L, et al. Case-control study of risk factors in cholangiocarcinoma[J]. Chin J Oncol, 2009, 31 (10) : 759-763. DOI: 10.3760/cma.j.issn.0253-3766.2009.10.010.
  • 8Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma [ J ]. HPB (Oxford), 2008, 10(2) :77-82. DOI:10.1080/13651820801992641.
  • 9Lee TY, Lin JT, Kuo KN, et al. A nationwide population-based study shows increasing incidence of cholangiocarcinoma [J]. Hepatol Int, 2013, 7 ( 1 ) : 226-232. DOI: 10.1007/s12072-012- 9369-0.
  • 10Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification[ J]. J Hepatobil Pancreat Surg, 2003, 10 (4) : 288-291. DOI : 10.1007/s00534-002-0732-8.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部